Compound ID | 113
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Fatty acid synthesis inhibitor. FabI inhibitor |
| Target Pathogen: | Designed for Burkholderia pseudomallei melioidosis |
| Institute where first reported: | Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA |
| Year first mentioned: | 2013 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5271320 |
| Citations: |
|
| Patent: | US10071965B2 |